Search details
1.
Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups.
Vox Sang
; 119(5): 447-459, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38419267
2.
Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection.
J Med Virol
; 95(1): e28331, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36415047
3.
Hepatitis C subtyping assay failure in UK patients born in sub-Saharan Africa: Implications for global treatment and elimination.
J Med Virol
; 95(1): e28178, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36168235
4.
Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors.
J Med Virol
; 95(10): e29144, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37796091
5.
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Liver Int
; 43(4): 917-927, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36708150
6.
Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study.
Epidemiol Infect
; 151: e59, 2023 03 14.
Article
in English
| MEDLINE | ID: mdl-36915219
7.
Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021.
Pediatr Nephrol
; 38(11): 3745-3755, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37261514
8.
Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.
J Infect Dis
; 225(12): 2142-2154, 2022 06 15.
Article
in English
| MEDLINE | ID: mdl-34979019
9.
The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks.
J Infect Dis
; 225(1): 10-18, 2022 01 05.
Article
in English
| MEDLINE | ID: mdl-34555152
10.
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa.
J Infect Dis
; 226(6): 995-1004, 2022 09 21.
Article
in English
| MEDLINE | ID: mdl-33668068
11.
Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.
J Gen Virol
; 103(3)2022 03.
Article
in English
| MEDLINE | ID: mdl-35230930
12.
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
J Gen Virol
; 102(6)2021 06.
Article
in English
| MEDLINE | ID: mdl-34130773
13.
Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.
J Viral Hepat
; 28(1): 168-176, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32978982
14.
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.
J Viral Hepat
; 28(9): 1256-1264, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34003556
15.
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
J Hepatol
; 73(6): 1368-1378, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32707225
16.
Epidemiology and natural history of hepatitis C virus infection among children and young people.
J Hepatol
; 70(3): 371-378, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30496763
17.
Testing for hepatitis C virus infection in UK prisons: What actually happens?
J Viral Hepat
; 26(6): 644-654, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30702194
18.
Trichodysplasia Spinulosa Polyomavirus in Respiratory Tract of Immunocompromised Child.
Emerg Infect Dis
; 24(9): 1744-1746, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30124403
19.
Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK.
J Med Virol
; 89(12): 2158-2164, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28480974
20.
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.
Hepatology
; 63(6): 1796-808, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26864802